Burden of Invasive Staphylococcus aureus Infections in Hospitalized Infants
- PMID: 26502073
- PMCID: PMC4694042
- DOI: 10.1001/jamapediatrics.2015.2380
Burden of Invasive Staphylococcus aureus Infections in Hospitalized Infants
Abstract
Importance: Staphylococcus aureus is a frequent cause of infection in hospitalized infants. These infections are associated with increased mortality and morbidity and longer hospital stays, but data on the burden of S aureus disease in hospitalized infants are limited.
Objectives: To compare demographics and mortality of infants with invasive methicillin-resistant S aureus (MRSA) and methicillin-susceptible S aureus (MSSA), to determine the annual proportion of S aureus infections that were MRSA, and to contrast the risk of death after an invasive MRSA infection with the risk after an invasive MSSA infection.
Design, setting, and participants: Multicenter retrospective study of a large, nationally representative cohort at 348 neonatal intensive care units managed by the Pediatrix Medical Group. Participants were 3888 infants with an invasive S aureus infection who were discharged from calendar year 1997 through calendar year 2012.
Exposure: Invasive S aureus infection.
Main outcomes and measures: The incidence of invasive S aureus infections, as well as infant characteristics and mortality after MRSA or MSSA infection.
Results: The 3888 infants had 3978 invasive S aureus infections (2868 MSSA and 1110 MRSA). The incidence of invasive S aureus infection was 44.8 infections per 10,000 infants. The yearly proportion of invasive infections caused by MRSA increased from calendar year 1997 through calendar year 2006 and has moderately decreased since then. Infants with invasive MRSA or MSSA infections had similar gestational ages and birth weights. Invasive MRSA infections occurred more often at a younger postnatal age. For infants with available mortality data, more infants with invasive MSSA infections (n = 237) died before hospital discharge than infants with invasive MRSA infections (n = 110). The proportions of infants who died after invasive MSSA and MRSA infections were similar at 237 of 2474 (9.6%) and 110 of 926 (11.9%), respectively (P = .05). The adjusted risk of death before hospital discharge was similar after invasive MSSA and MRSA infections (risk ratio, 1.19; 95% CI, 0.96-1.49). The risks of death at 7 and 30 days after invasive infection were similar between infants with invasive MSSA infection and infants with invasive MRSA infection.
Conclusions and relevance: Infant mortality after invasive MRSA and MSSA infections is similar, but MSSA causes more infections and more deaths in infants than MRSA. Measures to prevent S aureus infection should include MSSA in addition to MRSA.
Figures
Comment in
-
Spreading the Benefits of Infection Prevention in the Neonatal Intensive Care Unit.JAMA Pediatr. 2015 Dec;169(12):1089-91. doi: 10.1001/jamapediatrics.2015.2980. JAMA Pediatr. 2015. PMID: 26501886 No abstract available.
Similar articles
-
The epidemiology of methicillin-susceptible and methicillin-resistant Staphylococcus aureus in a neonatal intensive care unit, 2000-2007.J Perinatol. 2010 Feb;30(2):135-9. doi: 10.1038/jp.2009.119. Epub 2009 Aug 27. J Perinatol. 2010. PMID: 19710681
-
Spa Typing of Staphylococcus aureus in a Neonatal Intensive Care Unit During Routine Surveillance.J Pediatric Infect Dis Soc. 2021 Aug 17;10(7):766-773. doi: 10.1093/jpids/piab014. J Pediatric Infect Dis Soc. 2021. PMID: 34129043 Free PMC article.
-
Staphylococcus aureus, including community-acquired methicillin-resistant S. aureus, in a level III NICU: 2001 to 2008.Am J Perinatol. 2012 Jun;29(6):401-8. doi: 10.1055/s-0032-1304819. Epub 2012 Mar 7. Am J Perinatol. 2012. PMID: 22399220
-
Trends in invasive methicillin-resistant Staphylococcus aureus infections.Pediatrics. 2013 Oct;132(4):e817-24. doi: 10.1542/peds.2013-1112. Epub 2013 Sep 23. Pediatrics. 2013. PMID: 24062373 Review.
-
Staphylococcus aureus native arthritis over 10 years.Med Mal Infect. 2020 May;50(3):257-262. doi: 10.1016/j.medmal.2020.01.012. Epub 2020 Feb 11. Med Mal Infect. 2020. PMID: 32057526 Review.
Cited by
-
Association of Neonatal and Maternal Nasal Microbiome Among Neonates in the Intensive Care Unit.Open Forum Infect Dis. 2024 Oct 28;11(11):ofae644. doi: 10.1093/ofid/ofae644. eCollection 2024 Nov. Open Forum Infect Dis. 2024. PMID: 39544492 Free PMC article.
-
In silico studies on nicotinamide analogs as competitive inhibitors of nicotinamidase in methicillin-resistant Staphylococcus aureus.Mol Divers. 2024 Nov 13. doi: 10.1007/s11030-024-11036-y. Online ahead of print. Mol Divers. 2024. PMID: 39537945
-
Staphylococcal aureus outbreaks in neonatal intensive care units: strategies, nuances, and lessons learned from the frontline.Antimicrob Steward Healthc Epidemiol. 2024 May 2;4(1):e70. doi: 10.1017/ash.2024.59. eCollection 2024. Antimicrob Steward Healthc Epidemiol. 2024. PMID: 38721492 Free PMC article. Review.
-
A decade of neonatal sepsis in Stockholm, Sweden: Gram-positive pathogens were four times as common as Gram-negatives.Eur J Clin Microbiol Infect Dis. 2024 May;43(5):959-968. doi: 10.1007/s10096-024-04809-8. Epub 2024 Mar 22. Eur J Clin Microbiol Infect Dis. 2024. PMID: 38517573 Free PMC article.
-
Microbiome dysbiosis: a modifiable state and target to prevent Staphylococcus aureus infections and other diseases in neonates.J Perinatol. 2024 Jan;44(1):125-130. doi: 10.1038/s41372-023-01810-5. Epub 2023 Oct 30. J Perinatol. 2024. PMID: 37904005 Review.
References
-
- Verstraete E, Boelens J, De Coen K, et al. Healthcare-associated bloodstream infections in a neonatal intensive care unit over a 20-year period (1992-2011): trends in incidence, pathogens, and mortality. Infect Control Hosp Epidemiol. 2014;35(5):511–518. - PubMed
-
- Stoll BJ, Hansen NI, Adams-Chapman I, et al. Neurodevelopmental and growth impairment among extremely low-birth-weight infants with neonatal infection. JAMA. 2004;292(19):2357–2365. - PubMed
-
- Song X, Perencevich E, Campos J, Short BL, Singh N. Clinical and economic impact of methicillin-resistant Staphylococcus aureus colonization or infection on neonates in intensive care units. Infect Control Hosp Epidemiol. 2010;31(2):177–182. - PubMed
Publication types
MeSH terms
Grants and funding
- R03 AI117169/AI/NIAID NIH HHS/United States
- K24 HD058735/HD/NICHD NIH HHS/United States
- K24 AI093969/AI/NIAID NIH HHS/United States
- 1R01-HD081044-01/HD/NICHD NIH HHS/United States
- HHSN275201000003C/HD/NICHD NIH HHS/United States
- R01 AI068804/AI/NIAID NIH HHS/United States
- R01HS022872/HS/AHRQ HHS/United States
- UL1TR001117/TR/NCATS NIH HHS/United States
- UM1AI104681/AI/NIAID NIH HHS/United States
- R01 HS022872/HS/AHRQ HHS/United States
- HHSN275201000003I/HD/NICHD NIH HHS/United States
- R18 FD005292/FD/FDA HHS/United States
- 5T32HD060558/HD/NICHD NIH HHS/United States
- UL1 TR001117/TR/NCATS NIH HHS/United States
- T32 HD060558/HD/NICHD NIH HHS/United States
- HHSN272201500006C/AI/NIAID NIH HHS/United States
- 2K24HD058735-06/HD/NICHD NIH HHS/United States
- R03AI117169/AI/NIAID NIH HHS/United States
- R01 HD081044/HD/NICHD NIH HHS/United States
- R01-AI068804/AI/NIAID NIH HHS/United States
- K24-AI093969/AI/NIAID NIH HHS/United States
- UM1 AI104681/AI/NIAID NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
